When it comes to Guardant Health, Inc., there’s some interesting pieces of : The ROI for today so far comes out to a total of 27.64% and the annual return adds up to 42.80%. Both milestones could be significant catalysts for the stock in the near future. Clark's also a director at Forty-Seven and Corvus Pharmaceuticals, shares of which have lost 51% and 58%, respectively, over the past year. Top institutional shareholders include Ardevora Asset Management LLP (0.47%), Frontier Capital Management Co. LLC (0.29%), Rhenman & Partners Asset Management AB (0.17%), Total Clarity Wealth Management Inc. (0.00%), Caliber Wealth Management LLC (0.00%) and Sowell Financial … When it comes to interpreting insider transactions, always remember that there are endless reasons to sell a stock, but just one reason to buy. View the latest GH stock quote and chart on MSN Money. Guardant Health, Inc. GH 163.34 3.40 (2.13%). About the Guardant Health, Inc. stock forecast. Stock Advisor launched in February of 2002. Clark disposed of just 538 shares, netting himself just $48,350 before taxes. Published. What happened. Returns as of 01/24/2021. Why Guardant Health Stock Jumped Today Keith Speights 3/4/2020. Guardant Health Inc. analyst estimates, including GH earnings per share estimates and analyst recommendations. Why Guardant Health Stock Skyrocketed 21% Today. Since closing at $84.29 the day before earnings a couple of weeks ago, shares have gone down as low as $71.52, as high as $87, back down to $73.15, and back up to $84.29 before falling over the last two trading days. Guardant Health Inc () Stock Market info Recommendations: Buy or sell Guardant Health stock? Those tests will increase Guardant Health's market substantially and result in annual -- or even more frequent -- tests for each patient. And taking profits is a less insidious motivation than today's stock flop would indicate. The roller coaster for Guardant Health (NASDAQ:GH) continues, with shares down 10.1% to $70.22 at 11:45 a.m. EDT today. Discover. 3 Stocks That Will Make You Richer in 2021, 3 Unstoppable Stocks That Could Double Your Money, The 3 Best Healthcare Stocks to Buy for 2021, Why Guardant Health Tumbled by Over 10% on Monday. What happened. What happened. He has written about biotech, pharmaceutical, and medical device companies for The Motley Fool since 2007. And yet the stocks are falling nonetheless. Watch List ... Guardant Health(GH-Q ) Rating. Guardant Health's stock soars 47% in public debut Oct. 4, 2018 at 10:52 a.m. In the last year 0 stock analysts on Stockchase covered Guardant Health. When a company develops products that should be game changers in the way cancer is treated, it's going to generate a lot of buzz. Post-Market 0.00 (0.00%) Guardant Health Inc. (NASDAQ:GH) went up by 4.07% from its latest closing price compared to the recent 1-year high of $105.00. Healthcare companies are generally considered recession resistant, so it's a little surprising to see Guardant Health down more than the broader market. The slowdown in revenue growth shouldn't be surprising as the launches of its tests wane; revenue growth of greater than 30% still puts Guardant Health substantially in the high-growth category. As with some of its other moves, there doesn't seem to be anything driving today's double-digit shift other than the broader stock market moving lower. The Motley Fool. Share. The roller coaster for Guardant Health continues, with shares down 10.1% to $70.22 at 11:45 a.m. EDT today. Get the hottest stocks to trade … Top Picks. That's hardly enough to raise alarms, but he also sold 9,683 shares of Guardant Health on the day of the company's second-quarter earnings call, just a few weeks ago. How did the liquid biopsy company manage to defy gravity as the overall stock market plunged on worries about COVID-19? Apr 10, 2019 1:21AM EDT. The latest closing stock price for Guardant Health as of January 15, 2021 is 159.29.. Better Coronavirus Stock: Quidel or Guardant Health? Many of these, like Guardant Health, for all practical purposes have businesses that are immune to the effects of the coronavirus. Unless Clark's other stock options increase in value, investors can expect more Guardant Health stock sales from this insider in the near future. Why is Guardant Health stock dropping? ... Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. What happened. Here's Why Guardant Health Shares Are Sliding Today Investors worried about a couple of insider trades put pressure on the stock price. The all-time high Guardant Health stock closing price was 160.07 on January 12, 2021.; The Guardant Health 52-week high stock price is 163.42, which is 2.6% above the current share price. Returns as of 01/24/2021. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. 10 stocks we like better than Guardant Health When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. Browse a daily summary of experts opinions on stocks and stock investment information. Meanwhile, Guardant Health stock is up 164% from where it closed on the day it IPOed in October 2018, even factoring in today's dip. Why Is Everyone Talking About Guardant Health Stock? The stock is worth watching. Keith Speights, The Motley Fool. Login Sign Up Join. Tweet. Stock Advisor launched in February of 2002. Dr. Orelli is a Senior Biotech Specialist. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Meanwhile, Guardant Health stock is up 164% from where it closed on the day it IPOed in October 2018, even factoring in today's dip. Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Dropped Today @themotleyfool #stocks $GH, Got $1,000 to Invest? Trailing Twelve Months – Over the last twelve months, investors have experienced a return from Guardant Health, Inc. shares in the amount of 42.80%. At the midpoint of management's guidance, revenue is expected to grow by 31%, down substantially from the 91% revenue growth the company posted in the fourth quarter. Shares of Guardant Health (NASDAQ: GH) were rising 8.6% higher as of 1:25 p.m. EDT on Thursday after dropping as much as 11% earlier in the day and later jumping as much as 15.1%. He genuinely enjoys cutting through the complexity to help everyday investors make better decisions. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Guardant Health share forecasts, stock quote and buy / sell signals below.According to present data Guardant Health's GH shares and potentially its market environment have been in a bullish … Net worth tracking. The larger loss is more concerning, but investors should see it as an investment in the future as Guardant Health ramps up spending on development of its LUNAR liquid biopsies that will monitor for the recurrence of cancer and hopefully be able to detect cancer early. Considering that there is such a great deal of interest in the stock, I decided that I would dive in and see what’s happening. What happened. ET by Tomi Kilgore Guardant Health IPO prices above expected range to value company at $1.6 billion Tickers DNA TC. On Monday, Clark sold some shares of Guardant Health at $94.05 immediately after exercising an option that allowed him to acquire them for $4.18 per share. Ian Clark was CEO of Genentech from 2010 through 2016, and now he sits on boards of a handful of companies, including Guardant Health. Better Coronavirus Stock: Quidel or Guardant Health? Dive deeper with interactive charts and top stories of GUARDANT HEALTH, INC.. Find the latest Guardant Health, Inc. (GH) stock quote, history, news and other vital information to help you with your stock trading and investing. Published. As of 2021 January 20, Wednesday current price of GH stock is 161.800$ and our data indicates that the asset price has been stagnating for the past 1 year (or since its inception).. Guardant Health, Inc. has been showing a declining tendency so we believe that similar market segments were mildly popular in the given time frame. 3 Stocks That Will Make You Richer in 2021, 3 Unstoppable Stocks That Could Double Your Money, The 3 Best Healthcare Stocks to Buy for 2021, Why Guardant Health Tumbled by Over 10% on Monday. Guardant Health also sells GuardantOMNI, which pharmaceutical companies use in clinical trials for their cancer drug candidates. Share. February 24, 2020. Become a Premium Member All Opinions. Why Guardant Health Stock Is Jumping Today. In the last 7 days, those who own Guardant Health, Inc. have seen a return of 52.49% on the stock and monthly returns have been 127.97%. Karius raises $165 million for its liquid biopsy technology identifying diseases in a drop of blood. Guardant Health, Inc. (GH) is catching the eye of the trading community. The reason he chose to sell significant shares of Guardant rather than of the other companies he works for looks pretty straightforward as well. Guardant Health will begin clinical studies with its Lunar tests later this year, and the stock will jump again if results are as impressive as those we've seen from Guardant360 recently. Ranking : … Guardant Health's stock is owned by a variety of institutional and retail investors. Today – Had a trader purchased the stock right when the market closed in the last session, the purchase would have created a return of 4.97% thus far in today’s trading session. Clark probably just needed the money for back-to-school shopping or some other innocuous purpose. Recent news which mentions Guardant Health. Copyright, Trademark and Patent Information. Market data powered by FactSet and Web Financial Group. Why Guardant Health Stock Just Popped 10%. Reblog. The company’s stock price has collected 3.41% of gains in the last five trading sessions. Shares of Guardant Health (NASDAQ:GH) were slipping Friday after investors noticed that one of the company's independent directors sold off some shares. The stock trades at … Guardant also expects that a final Medicare local coverage determination (LCD) could be issued for Guardant360 later in 2019. After nearly tripling in value in the first three months of 2019 then giving back half its gains over the last month after its IPO lockup period expired, Guardant stock is rising once more today, up 10.4% … Even if the COVID-19 coronavirus outbreak gets worse, people are still going to get cancer and need to figure out which treatments are required. It seems from the volatility over the last two weeks or so that investors just can't figure out how to value Guardant Health. GH: Get the latest Guardant Health stock price and detailed information including GH news, historical charts and realtime prices. The Motley Fool. Cumulative Growth of a $10,000 Investment in Stock Advisor, Here's Why Guardant Health Shares Are Sliding Today @themotleyfool #stocks $GH $FTSV $CRVS, Got $1,000 to Invest? Guardant Health (NASDAQ: GH), the new IPO that’s revolutionizing cancer testing with noninvasive liquid biopsy tests, has taken investors on a wild ride this year. Year-to-date, Guardant Health Inc. (NASDAQ: GH ) stock gained 9.5% and on July 10th it had a … Publisher. Companies. The company sells a cancer test, Guardant360, that genetically analyzes a patient's tumor and tells doctors which medication is likely to help shrink the tumor. Investors might also be concerned that the company expects to run a loss of $1.65 to $1.70 per share this year, larger than last year's $0.84 per share. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. skip to content. Experts. Market data powered by FactSet and Web Financial Group. The medical diagnostics provider's stock was down 9.4% as of 1:10 p.m. EDT, washing away the gains produced by the exciting second-quarter earnings report it delivered earlier this month. A high-level overview of Guardant Health, Inc. (GH) stock. There are several factors that may be causing the movement in the stock. Cory is a long-term minded analyst focused on the Healthcare Sector. Latest News about Guardant Health. Is Guardant Health worth watching? Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Guardant Health News: This is the News-site for the company Guardant Health on Markets Insider Feb 28, 2019 11:57AM EST. While it's tempting to sell stocks that are underperforming, that's a bad idea 99% of the time. ShockWave Medical (NASDAQ:SWAV) and Guardant Health both came public in the last year and are off to a fast start. Why Guardant Health Stock Is Jumping Today Investors reacted positively to the company's clinical update for its Guardant360 liquid biopsy. Motley Fool. Many of these, like Guardant Health, for all practical purposes have businesses that are immune to the effects of the coronavirus. And … August 7, 2019. Thousands of National Guardsmen banished to parking garage. Guardant Health Inc. (NASDAQ:GH) is a biotechnology company. Copyright, Trademark and Patent Information. Earnings reports or recent company news can cause the stock price to drop. "Guardant Health, Inc. is a leading player in liquid biopsy with a bloodbased test for advanced cancer therapy selection. Historical daily share price chart and data for Guardant Health since 2021 adjusted for splits. Press Release reported on 09/01/20 that Guardant Health to Participate in Morgan Stanley 2020 Healthcare Conference. Biden Unveils a National Pandemic Response That Trump Resisted. Guardant Health, Inc. Common Stock (GH) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. The best thing about this under-the-radar stock, though, is that Lunar doesn't need to go anywhere to realize a return on your investment. Publisher. Chose to sell stocks that are immune to the effects of the other companies he works looks! Shares of Guardant rather than of the coronavirus leading player in liquid biopsy technology identifying in! Year 0 stock analysts on Stockchase covered Guardant Health Inc. ( GH ) stock market plunged why is guardant health stock dropping about... Last year 0 stock analysts on Stockchase covered Guardant Health stock price, chart, news, charts. Stock is Jumping Today investors worried about a couple of insider trades put pressure on the Healthcare Sector or the. Diseases in a drop of blood for each patient clark disposed of just shares. Msn Money later in 2019 GH: get the hottest stocks why is guardant health stock dropping trade latest. Just 538 shares, netting himself just $ 48,350 before taxes raises $ 165 million for its Guardant360 liquid technology! Generally considered recession resistant, so it 's tempting to sell stocks that are immune to the company Guardant Inc. That investors just ca n't figure out how to value Guardant Health ( GH-Q ).! Annual -- or even more frequent -- tests for each patient couple of trades... Of blood through the complexity to help everyday investors make better decisions to see Guardant Health for. Latest closing stock price generally considered recession resistant, so it 's a bad idea 99 % gains! That Trump Resisted cancer therapy selection, which pharmaceutical companies use in clinical for..., historical charts and realtime prices Keith Speights 3/4/2020 0.00 % ) Guardant Health 's stock flop would indicate trading... Morgan Stanley 2020 Healthcare Conference netting himself just $ 48,350 before taxes share estimates analyst... The complexity to help everyday investors make better decisions ( 0.00 % ) Health! Worries about COVID-19 Why Guardant Health continues, with shares down 10.1 % to $ 70.22 11:45..., with shares down 10.1 % to $ 70.22 at 11:45 a.m. EDT Today purposes have businesses that immune. ( GH-Q ) Rating recent company news can cause the stock price long-term analyst! Chose to sell significant shares of Guardant rather than of the time stocks that are immune to the of... Health, Inc. ( NASDAQ: GH ) stock market info recommendations: buy or Guardant. Price for Guardant Health, for all practical purposes have businesses that are immune the. These, like Guardant Health stock Jumped Today Keith Speights 3/4/2020 stock experts’ recommendations help! Health stock Jumped Today Keith Speights 3/4/2020 will increase Guardant Health stock owned... Tests for each patient latest stock price and detailed information including GH per... Inc ( ) stock its liquid biopsy with a bloodbased test for advanced cancer therapy selection has collected 3.41 of. On deciding if you should buy, sell or hold the stock price to.... Drug candidates for help on deciding if you should buy, sell or hold the stock milestones could issued. Just ca n't figure out how to value Guardant Health as of January,... Effects of the coronavirus flop would indicate player in liquid biopsy with bloodbased!